✦ LIBER ✦

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

✍ Scribed by M. Joerger; J. A. Burgers; P. Baas; V. D. Doodeman; P. H. M. Smits; R. S. Jansen; L. D. Vainchtein; H. Rosing; A. D. R. Huitema; J. H. Beijnen; J. H. M. Schellens

Publisher: Springer
Year: 2011
Tongue: English
Weight: 352 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1670-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Gemcitabine pharmacokinetics and interac

Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer

✍ Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

Effects of gemcitabine and cisplatin che

Effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients with RRM1 low protein expression

✍ Meiling Zhao; Haihong Yang; Jun liu; Yubao Guan; Mingchong Mo; Enyun Lin; Jianxi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 328 KB

Combination of low-dose cisplatin and ge

Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

✍ J. Feliu; G. Martín; C. Madroñal; A. Rodríguez-Jaráiz; J. Castro; A Rodríguez; T 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

Clinical observation of docetaxel plus c

Clinical observation of docetaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer

✍ Yongguang Cai; Ming Li; Xin Xie 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Pharmacokinetics of gemcitabine in non-s

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

✍ Jan Gerard Maring; Floris M. Wachters; Monique Slijfer; J. Marina Maurer; H. Mar 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 152 KB